Skip to main content

View full-text article in PMC

. 2010 Sep;5(9):1588–1594. doi: 10.2215/CJN.00210110

Table 1.

Demographic characteristics of study subjects

	Control Subjects NAC 600 mg	ESRD Subjects
	Control Subjects NAC 600 mg	NAC 600 mg	NAC 1200 mg
N	7	12	12
Age (yr)	44.9 ± 10.2	59.5 ± 14.0^a	49.8 ± 16.6
Sex (M/F)	2/5	8/4	7/5
Race (C/A/H)	5/1/1	8/4/0	4/8/0
Height (cm)	171.3 ± 13.7	171.7 ± 9.0	171.2 ± 14.6
Weight (kg)	68.9 ± 14.3	77.9 ± 13.7	95.6 ± 31.8^a
eGFR (ml/min per 1.73 m²)	89.3 ± 17.4	NA	NA

C, Caucasian; A, African American; H, Hispanic; eGFR, estimated glomerular filtration rate; NA, not applicable. Data expressed as mean ± SD.

^a

P < 0.05 versus control.